Literature DB >> 6492179

Cancer chemotherapy: past, present, and future--Part II.

J C Wright.   

Abstract

Cancer is of major concern today because of its high mortality. It is estimated that 66 million people in this country will eventually develop cancer; 1983 estimates were 855,000 new cases and 440,000 deaths from cancer.Because of limitations of surgery and radiation therapy in effecting a cure for cancer, chemotherapy has become increasingly important. The developments in the chemical control of cancer in man are encouraging.This two-part paper(*) covers the historical milestones in the development of the chemical and hormonal control of cancer, present successes with the use of polychemotherapy, and the hopeful trend in research.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6492179      PMCID: PMC2561656     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  32 in total

1.  COMBINED VINBLASTINE AND CHLORAMBUCIL THERAPY OF HODGKIN'S DISEASE.

Authors:  M J LACHER; J R DURANT
Journal:  Ann Intern Med       Date:  1965-03       Impact factor: 25.391

Review 2.  THE CURRENT STATUS OF CHEMOTHERAPY AND HORMONE THERAPY FOR CANCER.

Authors:  J C WRIGHT; T J MEDREK; D G WALKER; M M LYONS
Journal:  Prog Clin Cancer       Date:  1965

3.  Further investigation of the relation between the clinical and tissue culture response to chemotherapeutic agents on human cancer.

Authors:  J C WRIGHT; J P COBB; S L GUMPORT; D SAFADI; D G WALKER; F M GOLOMB
Journal:  Cancer       Date:  1962 Mar-Apr       Impact factor: 6.860

4.  Clinical drug dosages and duration of therapy of the cancer chemotherapeutic agents.

Authors:  J C WRIGHT
Journal:  Cancer Chemother Rep       Date:  1962-02

5.  Chemotherapy of human cancer by regional perfusion. Report of 52 perfusions.

Authors:  F M GOLOMB; A H POSTEL; A B HALL; S L GUMPORT; K R COX; J C WRIGHT
Journal:  Cancer       Date:  1962 Jul-Aug       Impact factor: 6.860

6.  Prophylactic and adjuvant use of nitrogen mustard in the surgical treatment of cancer.

Authors:  R MRAZEK; S ECONOMOU; G O MCDONALD; D P SLAUGHTER; W H COLE
Journal:  Ann Surg       Date:  1959-10       Impact factor: 12.969

7.  Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial.

Authors:  R Cash; A J Brough; M N Cohen; P S Satoh
Journal:  J Clin Endocrinol Metab       Date:  1967-09       Impact factor: 5.958

8.  Combination chemotherapy in the treatment of advanced Hodgkin's disease.

Authors:  V T Devita; A A Serpick; P P Carbone
Journal:  Ann Intern Med       Date:  1970-12       Impact factor: 25.391

9.  1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings.

Authors:  B Fisher; P Carbone; S G Economou; R Frelick; A Glass; H Lerner; C Redmond; M Zelen; P Band; D L Katrych; N Wolmark; E R Fisher
Journal:  N Engl J Med       Date:  1975-01-16       Impact factor: 91.245

10.  Use of in vitro tests in predictive cancer chemotherapy.

Authors:  A W Hamburger
Journal:  J Natl Cancer Inst       Date:  1981-06       Impact factor: 13.506

View more
  1 in total

Review 1.  Personalized Cancer Models for Target Discovery and Precision Medicine.

Authors:  Carla Grandori; Christopher J Kemp
Journal:  Trends Cancer       Date:  2018-08-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.